| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006885193 |
| P356 | DOI | 10.1007/S00280-009-1228-X |
| P698 | PubMed publication ID | 20082080 |
| P50 | author | Michael J. Boyer | Q56650502 |
| Tony Mok | Q61820649 | ||
| P2093 | author name string | R Lim | |
| M Millward | |||
| M M Moore | |||
| M Stockler | |||
| P2860 | cites work | Retinoids in cancer treatment | Q35536280 |
| Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma | Q41187515 | ||
| P433 | issue | 5 | |
| P921 | main subject | phase II clinical trial | Q42824440 |
| P304 | page(s) | 845-850 | |
| P577 | publication date | 2010-01-16 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group | |
| P478 | volume | 66 |
| Q92460577 | A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model |
| Q92091998 | A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors |
| Q43047273 | Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus |
| Q38847015 | Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation. |
| Q28552301 | Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids |
| Q38229062 | Gender specific issues in hereditary ocular disorders |
| Q92727373 | Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti |
| Q37721276 | Novel chemotherapeutic drugs in sphingolipid cancer research |
| Q37845832 | Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors |
| Q35137881 | Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles |
| Q50211518 | Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma |
| Q36301706 | Synthesis of short retinoidal amides related to fenretinide: antioxidant activities and differentiation-inducing ability. |
| Q58544569 | Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy |
Search more.